» Authors » Nitish Jangde

Nitish Jangde

Explore the profile of Nitish Jangde including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 63
Followers 0
Related Specialties
Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sinha S, Singh S, Jangde N, Ray R, Rai V
Cell Death Dis . 2021 Oct; 12(11):1012. PMID: 34711805
Melanoma originates from melanin-producing cells called melanocytes. Melanoma poses a great risk because of its rapid ability to spread and invade new organs. Cellular metastasis involves alteration in the gene...
2.
Ray R, Jangde N, Singh S, Sinha S, Rai V
Cell Commun Signal . 2020 Oct; 18(1):170. PMID: 33109194
Background: Receptor for advanced glycation end products (RAGE) is a multi-ligand transmembrane receptor of the immunoglobulin superfamily. Lysophosphatidic acid (LPA) is a ligand for RAGE and is involved in physiological...
3.
Jangde N, Ray R, Rai V
Crit Rev Biochem Mol Biol . 2020 Sep; 55(6):555-575. PMID: 32933340
Receptor for advanced glycation end products (RAGE) is an immunoglobulin-like receptor present on cell surface. RAGE binds to an array of structurally diverse ligands, acts as a pattern recognition receptor...
4.
Singh S, Sinha S, Padhan J, Jangde N, Ray R, Rai V
Med Oncol . 2020 Sep; 37(10):88. PMID: 32902730
Non-muscle myosin IIA heavy chain (MYH9) has been implicated in many physiological and pathological functions including cell adhesion, polarity, motility to cancer. However, its role in melanoma remains unexplored. The...
5.
Jangde N, Ray R, Sinha S, Rana K, Singh S, Khandagale P, et al.
Biochimie . 2018 Aug; 154:55-61. PMID: 30076903
Receptor for Advanced Glycation End product (RAGE) is a multiligand receptor implicated in diverse pathological conditions such as diabetes, atherosclerosis, cancer and neural diseases. Extracellular, RAGE consists of V, C1...